Senseonics HoldingsSENS +2.74%60 PS Ratio is 6.16 as of Jul. 07, 2026, which is 74% below its 10-year median of 24.06. GuruFocus rates SENS with a GF Score™ of 60/100 and a GF Value™ of $14.20 (Possible Value Trap). The stock has 3 warning signs investors should review. Among 805 Medical Devices & Instruments companies, Senseonics Holdings ranks worse than 75.28% on this metric.
The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. As of today, Senseonics Holdings's share price is $5.63.
Senseonics Holdings's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2026 was $0.91. Hence, Senseonics Holdings's PS Ratio for today is 6.16.
Good Sign:
Senseonics Holdings Inc stock PS Ratio (=6.01) is close to 5-year low of 5.5.
The historical rank and industry rank for Senseonics Holdings's PS Ratio or its related term are showing as below:
SENS'
s PS Ratio Range Over the Past 10 Years
Min: 4.34 Med: 24.06 Max: 20200
Current: 6.17
During the past 12 years, Senseonics Holdings's highest PS Ratio was 20200.00. The lowest was 4.34. And the median was 24.06.
SENS's PS Ratio is ranked worse than 75.28% of 805
companies
in the Medical Devices & Instruments industry
Industry Median: 2.94
vs SENS: 6.17
During the past 12 months, the average Revenue per Share Growth Rate of Senseonics Holdings was 27.30% per year.
During the past 3 years, the average Revenue per Share Growth Rate was 16.80% per year.
During the past 5 years, the average Revenue per Share Growth Rate was 12.20% per year.
During the past 12 years, Senseonics Holdings's highest 3-Year average Revenue per Share Growth Rate was 212.40% per year. The lowest was -38.30% per year. And the median was 3.30% per year.
Back to Basics: PS Ratio
Senseonics Holdings (NAS:SENS) PS Ratio Explanation
The PS Ratio is an excellent valuation indicator if you want to compare a stock with its historical valuation or with the stocks in the same industry. The PS Ratio works especially well when you want to compare the stock's current valuation with its historical valuation. The PS Ratio is a great valuation tool for evaluating cyclical businesses where the PE Ratio works poorly. It works the best when comparing the current valuation with the historical valuation because over time, a company's profit margin tends to revert to the mean.
When the PS Ratio is applied to the whole stock market, it can be used to evaluate the current market valuation and projected returns. In this case, the price is the total market cap of all stocks that are traded, and sales are the GDP of the country. This is how Warren Buffett estimates the broad market valuation and project future returns.
The PS Ratio does not tell you how cheap or expensive the stock is. It cannot be used to compare companies in different industries. It works better for companies within the same industry because these companies tend to have similar capital structures and profit margins. It works the best when comparing a company with itself in the past.
Senseonics Holdings PS Ratio Related Terms
Senseonics Holdings PS Ratio Historical Data
* Premium members only.
The historical data trend for Senseonics Holdings's PS Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, Senseonics Holdings's PS Ratio, along with its competitors' market caps and PS Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Senseonics Holdings PS Ratio vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Senseonics Holdings's PS Ratio distribution charts can be found below:
* The bar in red indicates where Senseonics Holdings's PS Ratio falls into.
The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. It is a ratio widely used to value stocks and it was first used by Ken Fisher.
Senseonics Holdings's Share Price of today is $5.63. Senseonics Holdings's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.91.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
Senseonics Holdings (SENS) has a PS Ratio of 6.16 as of Jul. 07, 2026. Price-to-Sales ratio is the ratio of share price to a company's revenue per share. View historical data on Senseonics Holdings and its competitors. This is 74% below median its historical median of 24.06. Over the past decade, Senseonics Holdings' PS Ratio has ranged from 4.34 to 20,200.00. According to the industry distribution chart, Senseonics Holdings ranks #606 out of 805 companies in the Medical Devices & Instruments industry, placing it in the top 75.3%.
Is Senseonics Holdings' PS Ratio too high?
Senseonics Holdings' current PS Ratio of 6.16 is 74% below median its 10-year median of 24.06. Over the past 10 years, this metric has ranged from a low of 4.34 to a high of 20,200.00. The Medical Devices & Instruments industry median PS Ratio is 2.94. Senseonics Holdings' value of 6.16 is 109.5% above this industry median. Based on the distribution chart, Senseonics Holdings ranks #606 out of 805 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, Senseonics Holdings has a GF Score™ of 60/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Senseonics Holdings' PS Ratio compare to LAB and TMCI?
According to the Medical Devices & Instruments industry distribution chart, Senseonics Holdings ranks #606 out of 805 companies for PS Ratio. This places Senseonics Holdings in the lower half of its industry. The industry median PS Ratio is 2.94. Senseonics Holdings' value of 6.16 is 109.5% above this benchmark. Historically, Senseonics Holdings' own PS Ratio has ranged from 4.34 to 20,200.00 over the past decade. While the company's 10-year median is 24.06 vs. the industry median of 2.94, Senseonics Holdings has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PS Ratio for a Medical Devices & Instruments company?
The median PS Ratio among Medical Devices & Instruments companies is 2.94, based on 805 companies in the industry. Companies in the top quartile (top 25%) have a PS Ratio significantly above this median, while those in the bottom quartile fall well below. However, PS Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Senseonics Holdings's current PS Ratio of 6.16 is 109.5% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PS Ratio mean?
A high PS Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Sales ratio is the ratio of share price to a company's revenue per share. View historical data on Senseonics Holdings and its competitors. For the Medical Devices & Instruments industry, the median PS Ratio is 2.94 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Senseonics Holdings's current PS Ratio is 6.16, which is 74% below median its own 10-year median of 24.06. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Senseonics Holdings stock overvalued right now?
Based on GuruFocus' analysis, Senseonics Holdings (SENS) is currently considered Possible Value Trap. The stock's GF Value™ is $14.20, compared to a current price of $5.63 — trading 60.4% below its estimated fair value. The current PS Ratio is 6.16, which is 74% below median its 10-year median of 24.06 and 109.5% above the Medical Devices & Instruments industry median of 2.94. Senseonics Holdings' overall GF Score™ is 60/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PS Ratio calculated?
PS Ratio is calculated from a company's financial statements. For Senseonics Holdings (SENS), the current PS Ratio is 6.16 as of Jul. 07, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Senseonics Holdings (SENS) Overvalued in 2026?
Based on GuruFocus' analysis, Senseonics Holdings stock appears to be undervalued.
The current stock price of $5.63 is trading 60.4% below its estimated GF Value™ of $14.20.
GuruFocus considers Senseonics Holdings to be Possible Value Trap.
Key valuation signals for SENS:
PS Ratio: 6.16 (74% below median its 10-year median of 24.06)
GF Value™: $14.20 vs. price of $5.63 (60.4% below fair value)
Industry Position: 109.5% above the Medical Devices & Instruments median (#606 of 805)
No single metric tells the full story. See the SENS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Senseonics Holdings Inc is a medical technology company focused on the development and commercialization of a long-term, implantable continuous glucose monitoring (CGM) system to improve the lives of people with diabetes by enhancing their ability to manage their disease with relative ease and accuracy. Its implantable CGM system, Eversense, including Eversense E3 and Eversense 365 CGM systems, measures glucose levels via an under-the-skin sensor, a removable and rechargeable smart transmitter, and an app for real-time diabetes monitoring and management. The company operates through one reportable segment which derives its revenues from diabetes products and services and generates the majority of its revenue from the United States.
60GF Score
Get the complete analysis for SENS
PS Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SENS has been successfully added to your 
